Disinfectant Residuals and Biofilm Control
An evidence-led guide for understanding biofilm in managed water and hygiene systems.
A measured disinfectant residual can be a useful operational indicator, but it is not a direct measurement of biofilm or a guarantee of control.
What a residual can tell you
Residual monitoring can help confirm whether an authorised treatment is reaching selected points. Sampling locations, method and timing should be defined in the site programme.
A result should be interpreted alongside system changes, demand, temperature, flow and microbiological evidence.
Avoiding over-interpretation
A residual at one point does not demonstrate conditions throughout complex pipework or on every surface. It should not be used to make unapproved efficacy claims.
2026 evidence: incoming residual and Legionella in ~5,600 buildings
The largest building-level dataset on this question so far was published in AWWA Water Science on 21 May 2026 (von Hagen et al., doi 10.1002/aws2.70055). In 2024 the US General Services Administration tested water quality, including Legionella, at roughly 8,250 federally owned and leased buildings. The study analysed summary results from about 5,600 of them, detailed laboratory reports from 40, and the chlorine or chloramine residuals recorded by the public water systems supplying them. About 23.6% of sampled building water systems had at least one total-Legionella exceedance. Older buildings (pre-1980s), larger buildings and health and human-services facilities showed higher exceedance rates.
On the residual question, the authors found no clear numeric distribution-system residual threshold that was consistently linked to lower Legionella occurrence in buildings. State minimum-residual requirements were not associated with a statistically significant difference in the proportion of buildings with exceedances, and chloraminated and free-chlorine systems did not differ significantly at the system level. In the temporally matched analysis of seven supplies, residuals near buildings with exceedances were often, but not always, lower than near buildings without, and exceedances occurred in buildings whose supplies were meeting their state minimums.
What the building study does and does not establish
It establishes that the residual arriving from the distribution main is a weak predictor, on its own, of whether Legionella will be found at outlets inside a building. That is consistent with the point of this guide: a residual measured at one location describes the water there, not the condition of the building's pipework, dead legs, storage and outlets. Building age, size and use were stronger correlates than the incoming residual. The disinfectants studied were chlorine and chloramine, not chlorine dioxide, and the study measured what public water systems delivered, not what any building dosed internally.
It does not establish that residuals are unimportant, nor does it test any secondary or supplementary disinfection inside buildings. The authors list substantial limitations: summary data recorded exceedances rather than concentrations; national residual data (2012–2020) were not contemporaneous with the 2024 building sampling; only 57% of buildings could be matched to a supplier; and detailed laboratory reports were available for just 40 buildings. The setting is US federal buildings under US rules, so the figures do not transfer to UK duty-holder obligations under ACOP L8 and HSG274. Nothing in the study speaks to ChloroKlean products.
Evidence and uncertainty
Published biofilm studies are valuable for understanding mechanisms, but their conditions may not match a particular installation. Species, surfaces, deposits and operating conditions should be recorded when interpreting evidence.
For safety-critical systems, decisions should be documented through the relevant risk assessment and management plan.
Choosing the next question
A useful next step is to identify what is known, what is inferred and what needs verification. This avoids treating a general reference as a site diagnosis.
Where a product is considered, confirm the intended use, authorisation and label directions independently of this educational guide.
A proportionate biofilm-management approach
Use this sequence to frame investigation and control; it is not a dosing protocol.
Define the system and risk
Map wetted surfaces, operating conditions, users and relevant legal or sector guidance.
Gather evidence
Review inspection, operational, residual and microbiological records rather than relying on one indicator.
Address contributing conditions
Consider cleaning, hydraulics, nutrients, stagnation and equipment condition alongside any authorised biocide programme.
Verify and review
Document the intervention and review results through the site’s written scheme or hygiene plan.
Expert Insights
"Biofilm control is a system-management question: chemistry, surfaces, flow, cleaning and verification all matter."
ChloroKlean Technical Team
Technical review team
About the Reviewer
Gavin Owen
Managing Director, ChloroKlean
Gavin Owen leads ChloroKlean's technical and commercial operations, bringing over 20 years of experience in industrial chemical distribution and water treatment. He oversees product development, regulatory compliance strategy, and the company's BPR compliance programme across PT2, PT4, PT5, and PT11 product types. Gavin works directly with water treatment professionals, facilities managers, and public health engineers across healthcare, leisure, food processing, and industrial sectors.
Frequently Asked Questions
Common questions about this topic, answered by our technical team.
Scope and safe-use note
- This is general educational information, not a dosing instruction or a product label.
- Use only a biocidal product authorised for its intended product type and follow its label, Safety Data Sheet and site risk assessment.
- Investigate system design, cleaning, monitoring and microbiological findings with a competent person where there is a health risk.
Published evidence about a disinfectant or another product does not establish efficacy, authorisation or an appropriate use pattern for any ChloroKlean product.
Related Resources
Continue exploring our knowledge base and product information.
Biofilm learning hub
Browse the connected biofilm guides.
PT5 drinking-water products
Potable-water application information.
Disinfectant depletion and regrowth in waterlines
Why a residual that depletes lets counts recover.
Legionella prevention in water systems
Building water-system risk management in the UK framework.
Legionella control
Legionella risk-management overview.
Sources & References
This article references guidance from the following authoritative sources:
- Biofilms: survival mechanisms of clinically relevant microorganisms
Industry Standard - Frontiers in Microbiology (PMC)
- Legionella and the prevention of legionellosis
WHO - World Health Organization
- ACOP L8: Legionnaires' disease
HSE - Health and Safety Executive
- Biocidal Products Regulation
ECHA - European Chemicals Agency
- Guidelines for Drinking-water Quality
WHO - World Health Organization
- Legionella occurrence in buildings: implications of public water system disinfectant and residual (21 May 2026)
Industry Standard - AWWA Water Science
External links open in a new window. ChloroKlean is not responsible for the content of external websites.